Abhiruchi Probiotics Pvt. Ltd.


Abhiruchi is a spin-off based on NCL ‘s technology created under Venture Center’s “Lab2Mkt” program . The company is working towards demonstrating the proof of concept for a novel formulation (patent protected) comprising a strain of Brevibacterium casei AP9 for a probiotic food additive, which will help reduce cholesterol absorption in the GI tract with potential long lasting action (as seen by higher and faster in-vitro Bile Salt Hydrolase(BSH) production than other LABs and as seen by higher adhesion to mucin layer). Abhiruchi has received Biotechnology Ignition Grant by DBT-BIRAC, GoI